Results 161 to 170 of about 150,303 (332)
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background The study objective was to compare the effectiveness of adalimumab (ADA) in monotherapy and in combination with methotrexate (MTX) for paediatric noninfectious uveitis (NIU). Methods Registry‐based observational study. Children receiving ADA for active uveitis were divided into the ADA monotherapy group (group 1) and the ADA plus ...
Carla Gaggiano +40 more
wiley +1 more source
American journal of ophthalmology-glaucoma, 2005 D. Jabs, R. Nussenblatt, J. Rosenbaum
semanticscholar +1 more source
Genetic Association of Primary Angle‐Closure Glaucoma and Disease Progression
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background To investigate single‐nucleotide polymorphisms (SNPs) reported in the largest up‐to‐date systematic review and meta‐analysis on primary angle‐closure disease (PACD), on their associations with primary angle‐closure glaucoma (PACG) and disease progression.
Yu Jing Liang +6 more
wiley +1 more source
Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease
American Journal of Ophthalmology Case Reports, 2018 Purpose: To report a case of pediatric Vogt-Koyanagi-Harada (VKH) successfully treated with infliximab and methotrexate for ten years. Observations: A 9-year-old Hispanic girl with VKH disease, was successfully treated with oral methotrexate 15 mg/week ...
Gustavo A. Budmann +2 more
doaj
Classification criteria for tubercular uveitis.
American journal of ophthalmology-glaucoma, 2021 The Standardization Of Uveitis Nomenclature Sun Wo +12 more
semanticscholar +1 more source
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background This study examines the long‐term effectiveness of anti‐VEGF therapy in managing neovascular age‐related macular degeneration (nAMD). Despite the well‐established short‐term improvements of anti‐VEGF therapy, there is limited data on its continued efficacy over extended periods.
Kimberly Spooner +5 more
wiley +1 more source
Primary CNS lymphoma with intravitreal metastasis : using vitreous cavity samples to monitor response to therapy [PDF]
, 2015 A fifty-eight year old male patient presented to the ophthalmic department with a 3 day history of reduced visual acuity, blurred vision and floaters, associated with recent lethargy, headaches and behavioural changes.
Aquilina, Nicola +5 more
core
Cell Proliferation, EarlyView.We generated immune‐tolerant mature hESC‐RPE cells by overexpressing PD‐L1. PD‐L1‐expressing hESC‐RPE grafts exhibited significantly higher survival, reduced apoptosis and enhanced visual protection in retinal degeneration models, which presents an alternative target to improve the efficiency of hESC‐RPE‐based therapy for AMD. ABSTRACT Immune rejection
Bowen Li +11 more
wiley +1 more source